Theranostic Porous Silicon Nanoparticles for the Diagnosis and Treatment of Thrombosis

The excessive forming of blood clots is a leading cause of death globally, and has gained particular attention during the COVID-19 pandemic. Medications that remove blood clots come with dangerous side effects, and diagnosis struggles to identify blood clots consistently. In this research, the delivery of these medications and imaging probes to the location of the blood clot is improved by incorporating them into nanometre-sized carriers. New, safer materials are developed and tested for the production of these carriers. The promising results of these tests indicate these carriers could be an excellent approach to improving the treatment of blood clots.